介绍医疗急救队 (MET) 系统:一个集群随机对照试验
Lancet (London, England)
|June 21, 2005
概括
实施医疗应急团队 (MET) 系统增加了紧急呼叫,但并没有显著减少心脏骤停,计划外的ICU入院或澳大利亚医院的死亡. 需要进一步的研究来优化MET的有效性.
科学领域:
- 医疗应急响应系统 医疗应急响应系统
- 医院患者安全 医院患者安全
- 临界护理干预措施 临界护理干预措施
背景情况:
- 一般病房中心脏骤停或死亡的患者的延迟或不充分的护理是一个重大问题.
- 医疗急救队 (MET) 系统是为了解决这些关键护理缺口而开发的.
研究的目的:
- 调查MET系统对减少心脏骤停,非计划性重症监护室 (ICU) 住院和住院死亡的影响.
- 评估全医院MET干预措施的有效性.
主要方法:
- 一项涉及23家澳大利亚医院的随机试验,其中11家控制医院和12家干预医院实施MET系统.
- 测量的主要结果是6个月的研究期间心脏骤停,意外死亡或计划外的ICU入院的复合.
- 用治疗意向分析来评估研究结果.
主要成果:
- 引入MET系统显著增加了紧急团队呼叫的发生率 (每1000例入院中有3.1人,而不是8.7人).
- 对照和MET医院之间的复合初级结果没有实质性的差异 (每1000例入院5.86对5.31).
- 个别结果,包括心脏骤停,计划外的ICU入院和意外死亡,在MET实施后没有显著减少.
结论:
- 该MET系统有效地增加了紧急响应小组的利用率.
- 在MET系统中,心脏骤停,计划外的ICU入院或意外死亡的发生率并没有显著减少.
相关概念视频
Multiple Comparison Tests
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


